Experienced in Thoracic Aortic Aneurysm

Igor Rudez

Zagreb, HR 
Experienced in Thoracic Aortic Aneurysm
Zagreb, HR 
OverviewLocationsClinical Research

Overview

Igor Rudez practices in Zagreb, Croatia. Mr. Rudez is rated as an Experienced expert by MediFind in the treatment of Thoracic Aortic Aneurysm. His top areas of expertise are Endocarditis, Dilated Cardiomyopathy (DCM), Aortic Regurgitation, Heart Valve Repair, and Heart Transplant.

His clinical research consists of co-authoring 43 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Thoracic Aortic Aneurysm.

Gender
Male

Locations

Zagreb, Croatia
Other Locations
Dubrovnik, Croatia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Randomized Comparison of the Clinical Outcome of Single Versus Multiple Arterial Grafts: the ROMA Trial
Randomized Comparison of the Clinical Outcome of Single Versus Multiple Arterial Grafts: the ROMA Trial
Enrollment Status: Active_not_recruiting
Publish Date: May 23, 2025
Intervention Type: Procedure
Study Phase: Not Applicable
A Multicenter, Randomized, Open-label, Parallel Group, Pilot Study to Evaluate the Use of Sacubitril/Valsartan in HeartMate 3 LVAD Recipients
A Multicenter, Randomized, Open-label, Parallel Group, Pilot Study to Evaluate the Use of Sacubitril/Valsartan in HeartMate 3 LVAD Recipients
Enrollment Status: Active_not_recruiting
Publish Date: March 27, 2024
Intervention Type: Drug
Study Drugs: Sacubitril-Valsartan, Standard of Care
Study Phase: Phase 4
View 1 Less Clinical Trial

43 Total Publications

Angiotensin-Neprilysin Inhibition and Left Ventricular Assist Device Therapy -Primary results of the multicENter, randomized, open-label, parallel group, study to evaluate the use of sacubitril/valsartan in HeartMate 3 LVAD recipients (ENVAD-HF).
Angiotensin-Neprilysin Inhibition and Left Ventricular Assist Device Therapy -Primary results of the multicENter, randomized, open-label, parallel group, study to evaluate the use of sacubitril/valsartan in HeartMate 3 LVAD recipients (ENVAD-HF).
Journal: JACC. Heart failure
Published: July 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Rudez's expertise for a condition
ConditionClose
      View All 21 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile